Prospective cohort study on the clinical significance of interferon-γ, D-dimer, LDH, and CRP tests in children with severe mycoplasma pneumonia

Yu-xiang Zhang,Yang Li,Yong Wang,You-feng Ren,Yue Yang,Jing Qi,Hui Yang,Xuan Liang,Rong-fang Zhang
DOI: https://doi.org/10.1097/md.0000000000039665
IF: 1.6
2024-10-15
Medicine
Abstract:Mycoplasma pneumoniae pneumonia (MPP) constitutes a significant respiratory infection in children, attributable to the unique Mycoplasma pneumonia (MP) microorganism. MPP has increasingly contributed to community-acquired pneumonia in children and adolescents, accounting for 10 to 40% of cases. [ 1 ] Its overall prevalence is estimated at 10% to 20% across all ages, [ 2 ] but rises above 50% in children older than 5. [ 3 ] Although MPP usually presents as a self-limiting condition of mild to moderate severity, [ 4 ] the incidence of severe mycoplasma pneumonia (SMPP) has escalated, propelled by the emergence of drug-resistant strains and advancements in diagnostic techniques. [ 5 ] Drug resistance, especially prevalent in East Asian countries like Japan, China, and South Korea, has become a major concern, with more than 70% of children showing resistance to MP treatments. [ 6 ]
medicine, general & internal
What problem does this paper attempt to address?